Diversified Growth Company - Medtech B EUR H/ LU2304352433 /
| NAV2024-05-24 | Chg.+0.1700 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 83.1500EUR | +0.20% | reinvestment | Equity | NS Partners ▶ |
Funds documents
| Date | Document | Year | Language | Filesize |
|---|---|---|---|---|
| 2024-05-29 | Public WebStation Live Factsheet | 2024 | English | - |
| 2023-06-30 | Semi-annual report | 2023 | English | 1,710.82 KB |
| 2023-04-28 | Prospectus | 2023 | English | 1,645.16 KB |
| 2023-04-28 | PRIIP Key Information Document | 2023 | English | 61.14 KB |
| 2022-12-31 | Account statment | 2022 | English | 2,748.60 KB |
| 2020-02-17 | Key Investor Information | 2020 | English | 462.54 KB |
